Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FST-201 in Acute Fungal Otitis Externa
NCT00945646Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jul 2009
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone and povidone-iodine in acute fungal otitis externa (2 arms), sponsored by Takeda. Primary endpoint: Overall clinical cure at 1 year. Started Jul 2009; status: terminated.
02
Drugs
dexamethasonepovidone-iodine
03
Conditions
acute fungal otitis externa
Beyond the preview
Go deeper on NCT00945646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945646.